A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main purpose of this study is to determine if combining tirzepatide with mibavademab will result in more weight loss in adult participants than tirzepatide alone. The study will last about 74 weeks and may include up to 19 visits.
Epistemonikos ID: d29d0dec3020bf1c4128b36bbfa595a44b3cb06e
First added on: Apr 19, 2024